Literature DB >> 11394407

Sucralfate: a help during oral management in patients with epidermolysis bullosa.

I Marini1, F Vecchiet.   

Abstract

BACKGROUND: Epidermolysis bullosa (EB) is a group of genetic disorders that lead to blister formation at variable depths in skin and mucosa. Vesicles may arise spontaneously or be caused by friction or trauma. Oral tissue fragility and blistering is common in all EB types. The majority of patients with mild forms of EB are able to receive dental treatment. The prevention of dental caries is most challenging in subjects with severe mucosal involvement, as they are least able to routinely undergo correct preventive procedures. The aim of this study was to evaluate the effectiveness of a sucralfate suspension in reducing both pain and the number of blisters in patients with EB, and to obtain improved oral hygiene and a lower incidence of caries.
METHODS: Five patients with dystrophic EB were treated with sucralfate suspension for the prevention and management of oral blisters. Oral blisters were assessed using a quantitative scale, while pain was assessed using visual analogue scale (VAS), and hygiene was evaluated through plaque and gingival indexes.
RESULTS: The number of blisters, oral pain, and plaque decreased in all cases.
CONCLUSIONS: Oral prophylaxis with sucralfate prevented oral blisters and oral discomfort. The procedure proved to be cost effective and easy to administer. It did not show significant side effects and may be used routinely in patients with EB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394407     DOI: 10.1902/jop.2001.72.5.691

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  12 in total

Review 1.  [Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].

Authors:  C Prodinger; A Diem; J W Bauer; M Laimer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 2.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

3.  Comparison of topical sucralfate with dexpanthenol in rat wound model.

Authors:  Eda Yildizhan; Burak Veli Ulger; Murat Akkus; Dilara Akinci; Omer Basol
Journal:  Int J Exp Pathol       Date:  2022-04-20       Impact factor: 2.793

4.  Case report: Dystrophic Epidermolysis Bullosa: dental management and oral health promotion.

Authors:  A K Louloudiadis; K A Louloudiadis
Journal:  Eur Arch Paediatr Dent       Date:  2009-01

5.  Pain care for patients with epidermolysis bullosa: best care practice guidelines.

Authors:  Kenneth R Goldschneider; Julie Good; Emily Harrop; Christina Liossi; Anne Lynch-Jordan; Anna E Martinez; Lynne G Maxwell; Danette Stanko-Lopp
Journal:  BMC Med       Date:  2014-10-09       Impact factor: 8.775

6.  Efficacy of topical sucralfate vERSUs silver sulfadiazine in the management of burns: A 1-year randomized controlled trial.

Authors:  A S Godhi; P Ram; R Powar
Journal:  J West Afr Coll Surg       Date:  2017 Jan-Mar

7.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11

8.  Epidermolysis bullosa, dental and anesthetic management: a case report.

Authors:  Katayoun Esfahanizade; Ali Reza Mahdavi; Ghassem Ansari; Masoud Fallahinejad Ghajari; Abdolreza Esfahanizadeh
Journal:  J Dent (Shiraz)       Date:  2014-09

9.  Pain in Patients with Dystrophic Epidermolysis Bullosa: Association with Anxiety and Depression.

Authors:  Giulio Fortuna; Massimo Aria; Rodrigo Cepeda-Valdes; Maria Guadalupe Moreno Trevino; Julio Cesar Salas-Alanís
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

10.  Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers.

Authors:  Subhrangsu Chatterjee; Sumit Sen; Avijit Hazra; Amal Kanti Das
Journal:  Indian J Pharmacol       Date:  2019-11-26       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.